A headshot photo of Werner Geldenhuys.

Werner Geldenhuys, PhD, MS

Associate Chair, Professor

Contact Information

PO Box 9530
108 Biomedical Road
BMRC 121
Morgantown, WV 26506


  • Pharmaceutical Sciences
  • Department of Neuroscience
  • Rockefeller Neuroscience Institute

Graduate Training

  • PhD in Medicinal Chemistry, North-West University, South Africa
  • MS in Pharmaceutical Chemistry, Potchefstroom University for CHE, South Africa


  • Postdoctoral Associate, Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech Health Sciences Center

Research Interests

My group focuses on the identification and development of novel therapeutics which can slow down the disease progression of Parkinson’s disease. Specifically, we focus on the mitochondrial protein mitoNEET. MitoNEET is a drug target for neurodegeneration. We use both small organic compounds and peptides drugs in our group. Additionally we use nanoparticles to deliver compounds and proteins to the brain to bypass the blood-brain barrier.


Research Topics

  • Parkinson's disease
  • Stroke
  • Alzheimer's disease
  • Drug discovery
  • Mitochondrial dysfunction
  • Neurodegeneration





More Publications

View More Publications